Cibus (CBUS) Other Accumulated Expenses (2017 - 2025)
Cibus (CBUS) posted Other Accumulated Expenses of $228000.0 for Q3 2025, down 23.23% sequentially from $297000.0 in Q2 2025, and up 7500.0% YoY from $3000.0 in Q3 2024.
Cibus (CBUS) Other Accumulated Expenses (2017 - 2025) Analysis & Trends
Cibus has reported Other Accumulated Expenses for 9 years, with the latest figure at $228000.0 in Q3 2025.
- Quarterly Other Accumulated Expenses rose 7500.0% year-over-year to $228000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $228000.0 (up 7500.0% YoY) and the FY2024 annual result came in at $288000.0, up 1700.0% from the prior year.
- Other Accumulated Expenses retreated to $228000.0 in Q3 2025 per CBUS's latest filing, from $297000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $483000.0 in Q1 2023 and troughed at $3000.0 in Q3 2024.
- A 5-year average of $185526.3 and a median of $175000.0 in 2022 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses slumped 97.72% in 2024, then surged 7500.0% in 2025.
- Over 5 years, Other Accumulated Expenses stood at $191000.0 in 2021, then dropped by 8.38% to $175000.0 in 2022, then plunged by 90.86% to $16000.0 in 2023, then soared by 1700.0% to $288000.0 in 2024, then declined by 20.83% to $228000.0 in 2025.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $228000.0, $297000.0, and $292000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 228,000.00 |
| Jun 30, 2025 | 297,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Dec 31, 2024 | 288,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 34,000.00 |
| Mar 31, 2023 | 483,000.00 |
| Dec 31, 2022 | 175,000.00 |
| Sep 30, 2022 | 397,000.00 |
| Jun 30, 2022 | 413,000.00 |
| Mar 31, 2022 | 435,000.00 |
| Dec 31, 2021 | 191,000.00 |
| Sep 30, 2021 | 147,000.00 |
| Jun 30, 2021 | 46,000.00 |
| Mar 31, 2021 | 45,000.00 |
| Dec 31, 2020 | 45,000.00 |